JPRN-UMIN000018949已完成未知
Comparison of efficacy of anagliptin and alogliptin for lipid profile between type 2 diabetic patients - Comparison of efficacy of anagliptin and alogliptin for lipid profile
niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine0 个研究点目标入组 100 人开始时间: 2015年9月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients using glinide and insulin therapy, those who were or may have been pregnant, and those with severe renal dysfunction (s-Cre levels: male>1.4mg/dl, female>1.2mg/dl) were excluded.
研究者
相似试验
已完成
4 期
Crossover evaluation of anagliptin versus sitagliptin on blood glucose levels using continuous glucose monitoring system in insulin-treated type 2 diabetes.type 2 diabetesJPRN-UMIN000024511Omori Red Cross Hospital16
招募中
2 期
Effect of Linagliptin and Empagliflozine on diabetesIRCT20221016056201N1Arak University of Medical Sciences55
招募中
4 期
Clinical efficacy of anagliptin administration in type 2 diabetic patientsType 2 DiabetesJPRN-UMIN000011071Kuwana East Medical Center Cardiology40
尚未招募
2 期
The effect of Alogliptin in the prevention of Type 1 Diabetes MellitusC18.452.394.750Type 1 Diabetes mellitusRBR-723bk5pniversidade Federal do Ceará
已完成
2 期
Comparison of vildagliptin and alogliptin in patient with type 2 diabetesType 2 diabetes mellitusJPRN-UMIN000005813Yokohama City University Medical Center70